• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Emerging therapies in AMD management

Video

Anat Loewenstein, MD, provides an update on the latest developments in emerging therapies for the management of age-related macular degeneration (AMD) and wet AMD.

Anat Loewenstein, MD, chair, Department of Ophthalmology, Tel Aviv Medical Center (Israel), provides an update on the latest developments in emerging therapies for the management of age-related macular degeneration (AMD) and wet AMD.

See more AMD Awareness content here, here, and here.

Related Videos
Related Content
Gene editing untangles one strand of the AMD web

Gene editing untangles one strand of the AMD web

Article
Ehsan Sadri, MD, leads an ophthalmology innovation discussion with Jeffry Weinhuff of Visionary Ventures

(EyePod) From idea to impact: Navigating ophthalmic innovation

Podcast
Using extracellular vesicles in the treatment of ocular diseases

Using extracellular vesicles in the treatment of ocular diseases

Article
Eyepod: Ocugen CEO gives update on OCU400

Eyepod: Ocugen CEO gives update on OCU400

Podcast
Treatment challenges in patients with nAMD

Treatment challenges in patients with nAMD

Article
Kiora Pharmaceuticals receives grant to fund novel clinical trial endpoints for inherited retinal diseases

Kiora Pharmaceuticals receives grant to fund novel clinical trial endpoints for inherited retinal diseases

Article
© 2024 MJH Life Sciences

All rights reserved.